May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Can Optical Coherence Tomography Predict the Outcome of Laser Photocoagulation for Diabetic Macular Edema?
Author Affiliations & Notes
  • E. Estabrook
    School of Medicine, University of Southampton, Southampton, United Kingdom
  • K. Madhusudhana
    Southampton Eye Unit, Southampton University Hospitals Trust, Southampton, United Kingdom
  • S. Hannan
    Southampton Eye Unit, Southampton University Hospitals Trust, Southampton, United Kingdom
  • R. Newsom
    Southampton Eye Unit, Southampton University Hospitals Trust, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships E. Estabrook, None; K. Madhusudhana, None; S. Hannan, None; R. Newsom, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Estabrook, K. Madhusudhana, S. Hannan, R. Newsom; Can Optical Coherence Tomography Predict the Outcome of Laser Photocoagulation for Diabetic Macular Edema?. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To assess the outcome of laser photocoagulation in patients with diabetic macular edema.

Methods:: Forty-seven patients (51 eyes) with clinically significant macular edema (CSME) undergoing grid laser photocoagulation were included. Clinical examination and optical coherence tomography (OCT) were performed at baseline and 3-4 months post-laser. The central foveal thickness (CFT), mean inner macular thickness (average retinal thickness in fovea and inner macular circle, IMT) and mean macular thickness (MMT) were calculated. Based on the OCT thickness, patients were grouped into; Group 1: Mild macular edema (<300 µm), Group 2: Moderate macular edema (300-399 µm) and Group 3: Severe macular edema (≥400 µm). Changes in CFT, IMT and MMT following laser treatment were noted.

Results:: Group 2 showed significant reductions in CFT (23µm, P=0.04), IMT (18 µm, P=0.02) and MMT (9 µm, P=0.04) with slight improvement in visual acuity. Groups 1 and 3 did not show any significant change in macular thickness values and there was a statistically insignificant worsening of visual acuity in these groups.

Conclusions:: Patients with moderate macular thickening of 300-400 µm do benefit most from laser treatment. OCT may help in choosing the appropriate treatment for CSME based on the degree of macular thickening. Long-term studies are warranted to confirm these findings. We have also described a relatively simple method of analysing the change in OCT thickness.

Keywords: macula/fovea • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×